Krom RA - Search Results

1

Hepatic allograft cyclosporine concentration is independent of the route of cyclosporine administration and correlates with the occurrence of early cellular rejection.

Sandborn WJ, Lawson GM, Krom RA, Wiesner RH. Sandborn WJ, et al. Among authors: krom ra. Hepatology. 1992 Jun;15(6):1086-91. doi: 10.1002/hep.1840150619. Hepatology. 1992. PMID: 1592348

2

The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation.

Ludwig J, Wiesner RH, Batts KP, Perkins JD, Krom RA. Ludwig J, et al. Among authors: krom ra. Hepatology. 1987 May-Jun;7(3):476-83. doi: 10.1002/hep.1840070311. Hepatology. 1987. PMID: 3552923

3

Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression.

Wijdicks EF, Wiesner RH, Krom RA. Wijdicks EF, et al. Among authors: krom ra. Neurology. 1995 Nov;45(11):1962-4. doi: 10.1212/wnl.45.11.1962. Neurology. 1995. PMID: 7501141

4

Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue.

Sandborn WJ, Lawson GM, Cody TJ, Porayko MK, Hay JE, Gores GJ, Steers JL, Krom RA, Wiesner RH. Sandborn WJ, et al. Among authors: krom ra. Hepatology. 1995 Jan;21(1):70-6. Hepatology. 1995. PMID: 7528712 Clinical Trial.

5

Soluble T lymphocyte markers in the diagnosis of cellular rejection and cytomegalovirus hepatitis in liver transplant recipients.

Ninova DI, Wiesner RH, Gores GJ, Harrison JM, Krom RA, Homburger HA. Ninova DI, et al. Among authors: krom ra. J Hepatol. 1994 Dec;21(6):1080-5. doi: 10.1016/s0168-8278(05)80621-x. J Hepatol. 1994. PMID: 7699231

6

OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation.

Portela D, Patel R, Larson-Keller JJ, Ilstrup DM, Wiesner RH, Steers JL, Krom RA, Paya CV. Portela D, et al. Among authors: krom ra. J Infect Dis. 1995 Apr;171(4):1014-8. doi: 10.1093/infdis/171.4.1014. J Infect Dis. 1995. PMID: 7706779

7

Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.

Sandborn WJ, Hay JE, Porayko MK, Gores GJ, Steers JL, Krom RA, Wiesner RH. Sandborn WJ, et al. Among authors: krom ra. Hepatology. 1994 Apr;19(4):925-32. Hepatology. 1994. PMID: 8138267

8

Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation.

Balan V, Batts KP, Porayko MK, Krom RA, Ludwig J, Wiesner RH. Balan V, et al. Among authors: krom ra. Hepatology. 1993 Dec;18(6):1392-8. Hepatology. 1993. PMID: 8244263

9

Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment.

Wiesner RH, Ludwig J, Krom RA, Hay JE, van Hoek B. Wiesner RH, et al. Among authors: krom ra. Mayo Clin Proc. 1993 Jan;68(1):69-79. doi: 10.1016/s0025-6196(12)60022-6. Mayo Clin Proc. 1993. PMID: 8417259 Review.

10

Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation.

Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Buckel EG, Steers JL, Wiesner RH, Krom RA. Sanchez-Urdazpal L, et al. Among authors: krom ra. Hepatology. 1993 Apr;17(4):605-9. doi: 10.1002/hep.1840170413. Hepatology. 1993. PMID: 8477965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters